|
SMC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33999999996082E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.64769999999992E-05 |
| Normal-vs-Stage2 |
1.377980E-04 |
| Normal-vs-Stage3 |
1.61030000001006E-06 |
| Normal-vs-Stage4 |
8.30030000000814E-05 |
| Stage1-vs-Stage2 |
3.453400E-01 |
| Stage1-vs-Stage3 |
1.461590E-01 |
| Stage1-vs-Stage4 |
4.775000E-01 |
| Stage2-vs-Stage3 |
9.096600E-01 |
| Stage2-vs-Stage4 |
8.238200E-01 |
| Stage3-vs-Stage4 |
7.034600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.23969999949503E-07 |
| Normal-vs-AfricanAmerican |
2.726400E-01 |
| Normal-vs-Asian |
2.199800E-03 |
| Caucasian-vs-AfricanAmerican |
3.224200E-02 |
| Caucasian-vs-Asian |
4.317800E-01 |
| AfricanAmerican-vs-Asian |
1.887380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.096900000361E-07 |
| Normal-vs-Female |
1.94369999999555E-05 |
| Male-vs-Female |
2.162000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.818600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.48430000004962E-06 |
| Normal-vs-Age(61-80Yrs) |
3.17920000003635E-06 |
| Normal-vs-Age(81-100Yrs) |
3.584600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.021000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.170000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.824600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.908000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.243600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.059600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.947980E-01 |
| Classical-VS-Follicular |
9.236600E-03 |
| Classical-VS-Other |
3.282000E-01 |
| Classical-VS-Normal |
1.645530E-04 |
| Tall-VS-Follicular |
7.154000E-01 |
| Tall-VS-Other |
7.616000E-01 |
| Tall-VS-Normal |
3.972500E-04 |
| Follicular-VS-Other |
9.310400E-01 |
| Follicular-VS-Normal |
1.57999999994551E-06 |
| Other-VS-Normal |
2.064000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.82010000030431E-07 |
| Normal-vs-N1 |
1.83214999999182E-05 |
| N0-vs-N1 |
5.575800E-01 |
|
|
